- Home
- CDXS vs DHY Comparison
CDXS vs DHY Comparison
Compare CDXS & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CDXS | DHY |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Finance/Investors Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.3M | 240.4M |
| IPO Year | 2008 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CDXS | DHY |
|---|---|---|
| Price | $2.29 | $1.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 756.7K | 584.5K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $138,590,000.00 | N/A |
| Revenue This Year | $7.73 | N/A |
| Revenue Next Year | $14.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.30 | N/A |
| 52 Week Low | $0.96 | $1.72 |
| 52 Week High | $3.87 | $2.16 |
Technical Indicators
Market Signals| Indicator | CDXS | DHY |
|---|---|---|
| Relative Strength Index (RSI) | 40.20 | 46.11 |
| Support Level | $1.57 | N/A |
| Resistance Level | $2.71 | $2.05 |
| Average True Range (ATR) | 0.17 | 0.02 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 1.44 | 39.13 |
Price Performance
Historical ComparisonAbout CDXS Codexis Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Credit Fund is a diversified, closed-end management investment company. The Fund's principal investment objective is to generate current income. Capital appreciation is a secondary objective, pursued to the extent consistent with the Fund's primary income objective.